Display options
Cite
Calaf GM, Urzua U, Termini L, et al. Oxidative stress in female cancers. Oncotarget. 2018;9(34):23824-23842doi: 10.18632/oncotarget.25323.
Calaf, G. M., Urzua, U., Termini, L., & Aguayo, F. (2018). Oxidative stress in female cancers. Oncotarget, 9(34), 23824-23842. https://doi.org/10.18632/oncotarget.25323
Calaf, Gloria M, et al. "Oxidative stress in female cancers." Oncotarget vol. 9,34 (2018): 23824-23842. doi: https://doi.org/10.18632/oncotarget.25323
Calaf GM, Urzua U, Termini L, Aguayo F. Oxidative stress in female cancers. Oncotarget. 2018 May 04;9(34):23824-23842. doi: 10.18632/oncotarget.25323. eCollection 2018 May 04. PMID: 29805775; PMCID: PMC5955122.
Copy Download .nbib Format: NLM
Share it on

Oncotarget. 2018 May 04;9(34):23824-23842. doi: 10.18632/oncotarget.25323. eCollection 2018 May 04.

Oxidative stress in female cancers.

Oncotarget

Gloria M Calaf, Ulises Urzua, Lara Termini, Francisco Aguayo

Affiliations

  1. Instituto de Alta Investigación (IAI), Universidad de Tarapacá, Arica, Chile.
  2. Center for Radiological Research, Columbia University Medical Center, New York, NY, USA.
  3. Departamento de Oncología Básico Clínica, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
  4. Instituto do Câncer do Estado de São Paulo, Centro de Investigação Translacional em Oncologia, Laboratório de Oncologia Experimental, São Paulo, SP, Brazil.
  5. Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Santiago, Chile.

PMID: 29805775 PMCID: PMC5955122 DOI: 10.18632/oncotarget.25323

Abstract

Breast, cervical and ovarian cancers are highly prevalent in women worldwide. Environmental, hormonal and viral-related factors are especially relevant in the development of these tumors. These factors are strongly related to oxidative stress (OS) through the generation of reactive oxygen species (ROS). The OS is caused by an imbalance in the redox status of the organism and is literally defined as "an imbalance between ROS generation and its detoxification by biological system leading to impairment of damage repair by cell/tissue". The multistep progression of cancer suggests that OS is involved in cancer initiation, promotion and progression. In this review, we described the role of OS and the interplay with environmental, host and viral factors related to breast, cervical and ovarian cancers initiation, promotion and progression. In addition, the role of the natural antioxidant compound curcumin and other compounds for breast, cervical and ovarian cancers prevention/treatment is discussed.

Keywords: breast; cervical; curcumin; ovarian cancer; oxidative stress

Conflict of interest statement

CONFLICTS OF INTEREST The authors declare no conflicts of interest

References

  1. Nat Rev Cancer. 2002 Jan;2(1):59-65 - PubMed
  2. J Med Virol. 2016 Feb;88(2):336-44 - PubMed
  3. Cancer Treat Res. 2005;126:103-27 - PubMed
  4. Cancer Lett. 2010 Mar 1;289(1):40-5 - PubMed
  5. Oncol Lett. 2017 Jun;13(6):4825-4831 - PubMed
  6. Arch Toxicol. 1984 Jul;55(2):110-8 - PubMed
  7. Mol Carcinog. 2007 Feb;46(2):130-43 - PubMed
  8. J Environ Pathol Toxicol. 1980 Nov;4(5-6):81-95 - PubMed
  9. Free Radic Res. 2010 May;44(5):479-96 - PubMed
  10. Arch Gynecol Obstet. 2017 Dec;296(6):1055-1062 - PubMed
  11. Mol Carcinog. 2006 Sep;45(9):701-9 - PubMed
  12. Toxicol Ind Health. 2012 Oct;28(9):852-63 - PubMed
  13. Endocr Rev. 2001 Apr;22(2):255-88 - PubMed
  14. Breast Cancer Res Treat. 1989 Jul;13(3):205-23 - PubMed
  15. Drug Resist Updat. 2004 Apr;7(2):97-110 - PubMed
  16. Virology. 2015 Feb;476:341-344 - PubMed
  17. Cancer Prev Res (Phila). 2018 Jan;11(1):59-67 - PubMed
  18. J Reprod Dev. 2012;58(1):44-50 - PubMed
  19. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7915-22 - PubMed
  20. Int J Cancer. 2014 Jun 15;134(12):2755-63 - PubMed
  21. Respir Res. 2007 Feb 08;8:10 - PubMed
  22. Int J Gynecol Pathol. 2008 Jan;27(1):1-9 - PubMed
  23. Carcinogenesis. 1997 Aug;18(8):1595-601 - PubMed
  24. Biochim Biophys Acta. 1994 Jan 3;1210(2):244-8 - PubMed
  25. J Natl Cancer Inst. 1996 Mar 6;88(5):291-6 - PubMed
  26. Oncol Rep. 2012 Aug;28(2):640-6 - PubMed
  27. Oxid Med Cell Longev. 2017;2017:3179421 - PubMed
  28. FEBS Lett. 2015 Mar 12;589(6):738-43 - PubMed
  29. Mol Carcinog. 2006 May;45(5):320-32 - PubMed
  30. Eur J Cancer. 2013 Apr;49(6):1374-403 - PubMed
  31. Vitam Horm. 2014;94:99-127 - PubMed
  32. Adv Exp Med Biol. 1994;364:101-7 - PubMed
  33. Cancer. 2002 Oct 15;95(8):1802-15 - PubMed
  34. J Nutr. 2000 Jan;130(1):10-4 - PubMed
  35. Exp Biol Med (Maywood). 2004 Jun;229(6):546-52 - PubMed
  36. Exp Cell Res. 2000 Nov 25;261(1):1-12 - PubMed
  37. Open Biol. 2017 Nov;7(11):null - PubMed
  38. Curr Drug Targets. 2011 Mar 1;12(3):332-47 - PubMed
  39. Biochem Pharmacol. 1998 Apr 1;55(7):965-73 - PubMed
  40. Biol Reprod. 2011 Apr;84(4):775-82 - PubMed
  41. Anim Reprod Sci. 2017 Jul;182:77-83 - PubMed
  42. J Biol Chem. 2006 May 12;281(19):13092-102 - PubMed
  43. J Virol. 2001 May;75(9):4467-72 - PubMed
  44. Biochem Pharmacol. 2009 Apr 15;77(8):1303-15 - PubMed
  45. Asian Pac J Cancer Prev. 2014;15(12):4745-51 - PubMed
  46. Breast Cancer. 2018 Mar;25(2):206-212 - PubMed
  47. Cancer. 1993 May 15;71(10):3036-43 - PubMed
  48. J Virol. 2005 Sep;79(17):11392-402 - PubMed
  49. Nat Rev Cancer. 2010 Aug;10(8):550-60 - PubMed
  50. J Virol Methods. 2009 Jun;158(1-2):180-3 - PubMed
  51. Toxicol Pathol. 2010 Jan;38(1):96-109 - PubMed
  52. J Carcinog. 2006 May 11;5:14 - PubMed
  53. J Virol. 2013 Jun;87(11):6062-72 - PubMed
  54. Am J Pathol. 2004 May;164(5):1511-8 - PubMed
  55. Br J Cancer. 1990 Feb;61(2):298-302 - PubMed
  56. Exp Mol Med. 2001 Dec 31;33(4):276-83 - PubMed
  57. Biol Reprod. 2012 Feb 09;86(2):27 - PubMed
  58. APMIS. 2010 Jun;118(6-7):471-93 - PubMed
  59. J Virol. 2005 Dec;79(23):14769-80 - PubMed
  60. Lancet Oncol. 2015 May;16(5):490-1 - PubMed
  61. J Natl Cancer Inst. 1975 Aug;55(2):231-73 - PubMed
  62. Chem Soc Rev. 2008 Nov;37(11):2558-74 - PubMed
  63. Annu Rev Cell Biol. 1994;10:405-55 - PubMed
  64. Adv Exp Med Biol. 2007;595:227-43 - PubMed
  65. J Surg Res. 2004 Oct;121(2):171-7 - PubMed
  66. Hum Reprod Update. 2007 Mar-Apr;13(2):143-62 - PubMed
  67. Virus Genes. 2015 Apr;50(2):210-20 - PubMed
  68. Biochem Biophys Res Commun. 2008 Jul 18;372(1):272-5 - PubMed
  69. Environ Health Perspect. 2002 Oct;110(10):1003-8 - PubMed
  70. Indian J Med Res. 2009 Sep;130(3):209 - PubMed
  71. Mol Cancer Ther. 2010 Mar;9(3):558-68 - PubMed
  72. Drug Deliv. 2016 Nov;23 (9):3665-3673 - PubMed
  73. Virology. 2009 Feb 20;384(2):375-9 - PubMed
  74. Exp Biol Med (Maywood). 2014 Jan;239(1):24-32 - PubMed
  75. Mol Carcinog. 2001 Aug;31(4):192-203 - PubMed
  76. Anticancer Res. 2005 Sep-Oct;25(5):3293-302 - PubMed
  77. Int J Oncol. 2006 Mar;28(3):667-74 - PubMed
  78. Cancer Immunol Immunother. 2018 May;67(5):761-774 - PubMed
  79. Free Radic Biol Med. 2010 Dec 15;49(12 ):2058-67 - PubMed
  80. Autophagy. 2017 Aug 3;13(8):1364-1385 - PubMed
  81. Viruses. 2015 Jul 16;7(7):3863-90 - PubMed
  82. J Biol Chem. 2002 Jul 12;277(28):25576-82 - PubMed
  83. Vaccine. 2012 Nov 20;30 Suppl 5:F12-23 - PubMed
  84. J Natl Cancer Inst. 1995 Feb 1;87(3):190-7 - PubMed
  85. Carcinogenesis. 2010 Nov;31(11):1905-12 - PubMed
  86. Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):437-42 - PubMed
  87. Oncol Rep. 2016 Oct;36(4):2207-15 - PubMed
  88. Neoplasia. 2010 Apr;12(4):317-25 - PubMed
  89. J Virol. 2000 Aug;74(16):7284-97 - PubMed
  90. Infect Agent Cancer. 2016 Nov 25;11:59 - PubMed
  91. BMC Cancer. 2002 Oct 13;2:24 - PubMed
  92. Reprod Toxicol. 2015 Dec;58:24-32 - PubMed
  93. Cancer Lett. 2008 Aug 18;267(1):133-64 - PubMed
  94. Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1462-7 - PubMed
  95. Oncol Rep. 2009 May;21(5):1209-14 - PubMed
  96. Clin Cancer Res. 2007 Jun 1;13(11):3423-30 - PubMed
  97. Mol Pharm. 2007 Nov-Dec;4(6):807-18 - PubMed
  98. BMC Cancer. 2001;1:1 - PubMed
  99. BMC Clin Pathol. 2015 Mar 03;15:3 - PubMed
  100. J Biol Chem. 1997 Mar 28;272(13):8482-9 - PubMed
  101. Endocrinology. 2006 Mar;147(3):1224-36 - PubMed
  102. Clin Exp Metastasis. 2008;25(6):643-55 - PubMed
  103. J Biol Chem. 1998 Mar 6;273(10):5858-68 - PubMed
  104. Oncotarget. 2017 Mar 29;8(37):60904-60916 - PubMed
  105. Cell Death Dis. 2017 Aug 17;8(8):e3001 - PubMed
  106. J Biol Chem. 2005 Dec 9;280(49):40428-35 - PubMed
  107. Expert Opin Ther Targets. 2007 Feb;11(2):109-10 - PubMed
  108. Nat Rev Cancer. 2010 Apr;10 (4):293-301 - PubMed
  109. Annu Rev Pathol. 2009;4:287-313 - PubMed
  110. DNA Repair (Amst). 2004 Aug-Sep;3(8-9):959-67 - PubMed
  111. Oxid Med Cell Longev. 2015;2015:454659 - PubMed
  112. Cancer Res. 1990 Sep 15;50(18):6075-86 - PubMed
  113. Annu Rev Pharmacol Toxicol. 2004;44:239-67 - PubMed
  114. Exp Physiol. 1997 Mar;82(2):291-5 - PubMed
  115. Carcinogenesis. 1996 Nov;17(11):2279-84 - PubMed
  116. Virology. 2013 Jan 20;435(2):357-62 - PubMed
  117. Cold Spring Harb Symp Quant Biol. 2005;70:209-15 - PubMed
  118. Chin Med J (Engl). 2017 May 5;130(9):1026-1032 - PubMed
  119. Clin Cancer Res. 2009 Mar 15;15(6):1853-9 - PubMed
  120. Curr Mol Med. 2016;16(3):243-51 - PubMed
  121. J Cell Sci. 1991 Jun;99 ( Pt 2):453-63 - PubMed
  122. Int J Mol Sci. 2014 Nov 25;15(12):21703-22 - PubMed
  123. Front Biosci (Schol Ed). 2013 Jan 01;5:709-19 - PubMed
  124. Future Virol. 2011 Jan 1;6(1):45-57 - PubMed
  125. PLoS One. 2015 Jun 01;10(6):e0127551 - PubMed
  126. Exp Biol Med (Maywood). 2010 May;235(5):561-8 - PubMed
  127. Science. 2013 Feb 8;339(6120):694-8 - PubMed
  128. Bioinformatics. 2009 Mar 15;25(6):838-40 - PubMed
  129. Carcinogenesis. 2000 Apr;21(4):769-76 - PubMed
  130. Cancer Res. 1980 Aug;40(8 Pt 1):2677-87 - PubMed
  131. Endocr Rev. 2007 Jun;28(4):440-61 - PubMed
  132. Toxicol Appl Pharmacol. 2011 Jul 15;254(2):86-99 - PubMed
  133. Oncogene. 1999 Dec 20;18(55):7908-16 - PubMed
  134. Mutat Res. 2011 Jun 3;711(1-2):193-201 - PubMed
  135. Cancer Lett. 2000 Apr 3;151(1):87-95 - PubMed
  136. Tumour Biol. 2016 Oct;37(10 ):13017-13028 - PubMed
  137. J Virol. 1993 Nov;67(11):6476-86 - PubMed
  138. Cancer Lett. 2012 Dec 31;327(1-2):48-60 - PubMed
  139. Biochim Biophys Acta. 2015 Aug;1850(8):1622-32 - PubMed
  140. J Ovarian Res. 2014 May 10;7:52 - PubMed
  141. Nutr Cancer. 2017 Apr;69(3):365-374 - PubMed
  142. Dis Markers. 2011;30(6):275-81 - PubMed
  143. Rev Chilena Infectol. 2014 Apr;31(2):196-203 - PubMed
  144. Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10937-42 - PubMed
  145. Mini Rev Med Chem. 2017;17 (11):904-919 - PubMed
  146. Biochem Pharmacol. 2009 Nov 15;78(10 ):1305-15 - PubMed
  147. Cancer Sci. 2007 Oct;98(10):1505-11 - PubMed
  148. Nutrients. 2016 Nov 10;8(11): - PubMed
  149. Reprod Biol Endocrinol. 2012 Jun 29;10:49 - PubMed
  150. Oncogene. 2009 May 21;28(20):2074-86 - PubMed
  151. Cancer Res. 1983 Nov;43(11):5200-4 - PubMed
  152. Amino Acids. 2012 Jan;42(1):139-58 - PubMed
  153. Carcinogenesis. 2015 Nov;36(11):1419-28 - PubMed
  154. Mol Cell Biochem. 2010 Mar;336(1-2):25-37 - PubMed
  155. Biol Res Nurs. 2009 Apr;10(4):392-9 - PubMed
  156. Mutat Res Genet Toxicol Environ Mutagen. 2014 Sep 1;771:43-52 - PubMed
  157. PLoS One. 2016 Dec 9;11(12 ):e0167869 - PubMed
  158. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3913-8 - PubMed
  159. Transl Oncol. 2010 Apr;3(2):99-108 - PubMed
  160. Cell Stress Chaperones. 2012 Jan;17(1):11-21 - PubMed
  161. Gynecol Oncol. 2014 Feb;132(2):322-7 - PubMed
  162. Int J Cancer. 2003 Mar 1;103(6):730-7 - PubMed
  163. FASEB J. 1999 Jan;13(1):69-79 - PubMed
  164. Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):715-20 - PubMed
  165. Oncotarget. 2017 Jul 10;8(36):60299-60311 - PubMed
  166. Carcinogenesis. 2008 Sep;29(9):1742-50 - PubMed
  167. Oncotarget. 2016 Dec 27;7(52):86374-86387 - PubMed
  168. Carcinogenesis. 2013 May;34(5):1125-33 - PubMed
  169. Nucleic Acids Res. 2015 Jan;43(Database issue):D1049-56 - PubMed
  170. Int J Oncol. 2012 Feb;40(2):436-42 - PubMed
  171. Nat Rev Drug Discov. 2009 Jul;8(7):579-91 - PubMed
  172. PLoS One. 2013 Sep 24;8(9):e75625 - PubMed
  173. Int J Vitam Nutr Res. 1993;63(2):93-121 - PubMed
  174. Cancer Lett. 2001 Apr 10;165(1):1-10 - PubMed
  175. J Biol Chem. 2005 May 20;280(20):20059-68 - PubMed
  176. Annu Rev Physiol. 2002;64:69-92 - PubMed
  177. Oncogene. 2008 Sep 25;27(43):5662-71 - PubMed
  178. BMC Genomics. 2016 Oct 25;17 (Suppl 8):728 - PubMed
  179. Antioxid Redox Signal. 2000 Winter;2(4):903-17 - PubMed
  180. Free Radic Biol Med. 2004 Mar 15;36(6):718-44 - PubMed
  181. Oxid Med Cell Longev. 2017;2017:7454031 - PubMed
  182. Clin Obstet Gynecol. 2012 Mar;55(1):3-23 - PubMed
  183. Biochim Biophys Acta. 1989 Jan 19;994(1):30-6 - PubMed
  184. J Biol Chem. 2012 Feb 10;287(7):4434-40 - PubMed
  185. Mol Cell Biol. 2000 May;20(10):3685-94 - PubMed
  186. Int J Oncol. 2011 Jun;38(6):1703-11 - PubMed
  187. Free Radic Res. 2006 Apr;40(4):393-402 - PubMed
  188. Eur J Cancer. 1993;29A(9):1335-44 - PubMed
  189. Drug Metab Rev. 2006;38(1-2):171-96 - PubMed
  190. Reprod Biol Endocrinol. 2009 Dec 05;7:143 - PubMed
  191. Am J Epidemiol. 2005 Nov 15;162(10):943-52 - PubMed
  192. Br J Cancer. 2009 Nov 17;101(10):1798-804 - PubMed
  193. Oncol Rep. 2011 Oct;26(4):1029-35 - PubMed
  194. Cancer Cell. 2006 Sep;10(3):175-6 - PubMed
  195. J Virol. 1997 Jan;71(1):362-70 - PubMed
  196. Virology. 2012 Mar 30;425(1):53-60 - PubMed
  197. Int J Mol Sci. 2017 Feb 09;18(2): - PubMed
  198. Mol Cell Biochem. 2014 Apr;389(1-2):99-111 - PubMed

Publication Types